Cargando…
Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients
Paraoxonase 1 (PON1) is known for preventing atherosclerosis through lipid-modifying features, antioxidant activity, anti-inflammatory, anti-apoptosis, anti-thrombosis, and anti-adhesion properties. Uremic patients requiring haemodialysis (HD) are especially prone to atherosclerosis and its complica...
Autores principales: | Grzegorzewska, Alicja E., Adamska, Paulina, Iwańczyk-Skalska, Ewa, Ostromecka, Kamila, Niepolski, Leszek, Marcinkowski, Wojciech, Mostowska, Adrianna, Warchoł, Wojciech, Żaba, Czesław, Jagodziński, Paweł P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990965/ https://www.ncbi.nlm.nih.gov/pubmed/33762698 http://dx.doi.org/10.1038/s41598-021-86231-0 |
Ejemplares similares
-
ENHO, RXRA, and LXRA polymorphisms and dyslipidaemia, related comorbidities and survival in haemodialysis patients
por: Grzegorzewska, Alicja E., et al.
Publicado: (2018) -
Paraoxonase 1 gene variants concerning cardiovascular mortality in conventional cigarette smokers and non-smokers treated with hemodialysis
por: Grzegorzewska, Alicja E., et al.
Publicado: (2021) -
Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case–control study
por: Grzegorzewska, Alicja E., et al.
Publicado: (2021) -
Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study
por: Grzegorzewska, Alicja E., et al.
Publicado: (2021) -
Associations of the calcium-sensing receptor gene CASR rs7652589 SNP with nephrolithiasis and secondary hyperparathyroidism in haemodialysis patients
por: Grzegorzewska, Alicja E., et al.
Publicado: (2016)